• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.

作者信息

Tomaselli Gordon F, Mahaffey Kenneth W, Cuker Adam, Dobesh Paul P, Doherty John U, Eikelboom John W, Florido Roberta, Gluckman Ty J, Hucker William J, Mehran Roxana, Messé Steven R, Perino Alexander C, Rodriguez Fatima, Sarode Ravindra, Siegal Deborah M, Wiggins Barbara S

出版信息

J Am Coll Cardiol. 2020 Aug 4;76(5):594-622. doi: 10.1016/j.jacc.2020.04.053. Epub 2020 Jul 14.

DOI:10.1016/j.jacc.2020.04.053
PMID:32680646
Abstract
摘要

相似文献

1
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.2020年美国心脏病学会口服抗凝剂治疗患者出血管理专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2020 Aug 4;76(5):594-622. doi: 10.1016/j.jacc.2020.04.053. Epub 2020 Jul 14.
2
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.2017年美国心脏病学会口服抗凝剂治疗患者出血管理专家共识决策路径：美国心脏病学会专家共识决策路径特别工作组报告
J Am Coll Cardiol. 2017 Dec 19;70(24):3042-3067. doi: 10.1016/j.jacc.2017.09.1085. Epub 2017 Dec 1.
3
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.2020年美国心脏病学会解决方案集监督委员会报告：经皮冠状动脉介入治疗或患有动脉粥样硬化性心血管疾病的心房颤动或静脉血栓栓塞患者的抗凝和抗血小板治疗专家共识决策路径
J Am Coll Cardiol. 2021 Feb 9;77(5):629-658. doi: 10.1016/j.jacc.2020.09.011. Epub 2020 Nov 26.
4
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.当代口服抗凝剂在亚洲非瓣膜性心房颤动患者中的疗效和安全性。
Stroke. 2019 Aug;50(8):2245-2249. doi: 10.1161/STROKEAHA.119.025536. Epub 2019 Jun 18.
5
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.一项全国性注册研究，旨在比较服用口服抗凝剂的心房颤动患者的出血率。
Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):28-36. doi: 10.1093/ehjcvp/pvw031. Epub 2016 Sep 27.
6
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.达比加群、利伐沙班和阿哌沙班与华法林相比治疗非瓣膜性心房颤动的有效性和安全性。
J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.
7
Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation.直接口服抗凝剂与华法林在伴有慢性肾脏病和心房颤动的 Medicare 患者中的比较。
Stroke. 2020 Aug;51(8):2364-2373. doi: 10.1161/STROKEAHA.120.028934. Epub 2020 Jul 9.
8
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.非维生素K口服抗凝药用于非瓣膜性心房颤动的相对疗效和安全性：在三个患者亚组中比较阿哌沙班、达比加群、利伐沙班和依度沙班的网状Meta分析
Int J Cardiol. 2016 Feb 1;204:88-94. doi: 10.1016/j.ijcard.2015.11.084. Epub 2015 Nov 17.
9
Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.房颤冷冻球囊消融术患者中抗凝剂相关出血和缺血并发症的比较研究
J Cardiol. 2017 Jan;69(1):11-15. doi: 10.1016/j.jjcc.2016.04.009. Epub 2016 May 7.
10
Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies.非瓣膜性心房颤动中直接口服抗凝剂的老年出血风险：队列研究的系统评价和荟萃分析。
Drugs R D. 2019 Sep;19(3):235-245. doi: 10.1007/s40268-019-0275-y.

引用本文的文献

1
The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.早期康复在急性肺栓塞治疗中的作用——一项叙述性综述
J Clin Med. 2025 Sep 3;14(17):6230. doi: 10.3390/jcm14176230.
2
Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Reversal of Anticoagulation: Evaluation of Efficacy, Safety, and Cost Savings.用于逆转抗凝的固定剂量四因子凝血酶原复合物浓缩剂：疗效、安全性及成本节约评估
J Hematol. 2025 Aug 7;14(4):234-239. doi: 10.14740/jh2078. eCollection 2025 Aug.
3
Airway obstruction in a man with warfarin-induced sublingual and pharyngeal haematomas.
一名服用华法林后出现舌下和咽部血肿的男性患者的气道阻塞
BMJ Case Rep. 2025 Aug 28;18(8):e264280. doi: 10.1136/bcr-2024-264280.
4
Comparative Safety of Anticoagulant, Antiplatelet and the Combination of Both for Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.抗凝剂、抗血小板药物及其联合应用治疗急性冠脉综合征的比较安全性：一项系统评价和网状Meta分析
Biomedicines. 2025 Aug 20;13(8):2027. doi: 10.3390/biomedicines13082027.
5
Risk factors and prevention strategies for complications following thyroid radiofrequency ablation: A review.甲状腺射频消融术后并发症的危险因素及预防策略：综述
Medicine (Baltimore). 2025 Aug 22;104(34):e44039. doi: 10.1097/MD.0000000000044039.
6
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect in Athletes: A Study With a Long-Term Follow-Up.运动员卵圆孔未闭和房间隔缺损的经皮封堵术：一项长期随访研究
Scand J Med Sci Sports. 2025 Aug;35(8):e70116. doi: 10.1111/sms.70116.
7
Bleeding-Related Hospitalizations Among Direct Oral Anticoagulant Users and Nonusers in Medicare Fee-For-Service: Variation in Prevalence, Burden, and Characteristics.医疗保险按服务收费项目中直接口服抗凝剂使用者和非使用者与出血相关的住院情况：患病率、负担及特征的差异
Adv Ther. 2025 Jul 22. doi: 10.1007/s12325-025-03287-4.
8
Factor XIa Inhibitors Versus Direct Oral Anticoagulants for Atrial Fibrillation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.用于心房颤动的凝血因子XIa抑制剂与直接口服抗凝剂：一项随机对照试验的系统评价和荟萃分析
Cardiovasc Drugs Ther. 2025 Jun 25. doi: 10.1007/s10557-025-07741-x.
9
Management of anaemia in critically ill adults.危重症成年患者贫血的管理
Singapore Med J. 2025 May 1;66(5):283-290. doi: 10.4103/singaporemedj.SMJ-2024-005. Epub 2025 May 19.
10
Anticoagulant prescribing trends, bleeding events, and reversal agent use in pediatric patients: A retrospective, real-world study.儿科患者的抗凝药物处方趋势、出血事件及逆转剂使用情况：一项回顾性真实世界研究。
PLoS One. 2025 May 8;20(5):e0323137. doi: 10.1371/journal.pone.0323137. eCollection 2025.